Related Experiment Video
Updated: Oct 1, 2026

Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques
Published on: June 1, 2016
Chronic stress as a risk factor for Alzheimer's disease: Roles of microglia-mediated synaptic remodeling,
Kanchan Bisht1, Kaushik Sharma1, Marie-Ève Tremblay1,2
1Axe Neurosciences, CRCHU de Québec-Université Laval, Québec, QC, Canada.
Abstract:
Microglia are the predominant immune cells of the central nervous system (CNS) that exert key physiological roles required for maintaining CNS homeostasis, notably in response to chronic stress, as well as mediating synaptic plasticity, learning and memory. The repeated exposure to stress confers a higher risk of developing neurodegenerative diseases including sporadic Alzheimer's disease (AD). While microglia have been causally linked to amyloid beta (Aβ) accumulation, tau pathology, neurodegeneration, and synaptic loss in AD, they were also attributed beneficial roles, notably in the phagocytic elimination of Aβ. In this review, we discuss the interactions between chronic stress and AD pathology, overview the roles played by microglia in AD, especially focusing on chronic stress as an environmental risk factor modulating their function, and present recently-described microglial phenotypes associated with neuroprotection in AD. These microglial phenotypes observed under both chronic stress and AD pathology may provide novel opportunities for the development of better-targeted therapeutic interventions.
Insights
Chronic stress impacts microglia, the brain's immune cells, increasing Alzheimer's disease (AD) risk. Understanding these stress-modulated microglial functions offers new therapeutic targets for AD.
Area of Science:
- Neuroscience
- Immunology
- Neurodegenerative Diseases
Background:
- Microglia are central nervous system (CNS) immune cells vital for homeostasis, synaptic plasticity, learning, and memory.
- Chronic stress is a significant risk factor for neurodegenerative diseases like Alzheimer's disease (AD).
- Microglia play complex roles in AD, contributing to pathology (Aβ accumulation, tau tangles) and potentially offering neuroprotection (Aβ phagocytosis).
Purpose of the Study:
- To review the intricate relationship between chronic stress and Alzheimer's disease (AD) pathology.
- To elucidate the multifaceted roles of microglia in AD pathogenesis.
- To highlight stress-induced microglial phenotypes and their potential for neuroprotection in AD.
Main Methods:
- Literature review focusing on the interplay between chronic stress, microglial function, and AD.
- Analysis of current research on microglial phenotypes in the context of stress and AD.
- Synthesis of findings to identify therapeutic opportunities.
Main Results:
- Chronic stress significantly modulates microglial functions, influencing AD risk and progression.
- Specific microglial phenotypes associated with both neuroprotection and neurodegeneration under chronic stress and AD conditions have been identified.
- These phenotypes offer insights into the dual role of microglia in AD.
Conclusions:
- Chronic stress is a critical environmental factor influencing microglial activity in AD.
- Targeting stress-modulated microglial phenotypes presents a promising avenue for developing novel AD therapeutics.
- Further research into these specific microglial states could lead to more effective interventions for AD patients.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Psychoneuroimmunology: Diabetes and Cancer
Alzheimer Disease l: Introduction
Alzheimer Disease ll: Pathophysiology

